🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Eli Lilly patient assistance programs — looking for input

Eli Lilly patient assistance programs — looking for input

pam_stl Tue, Nov 11, 2025 at 2:34 PM 27 replies 1,587 viewsPage 1 of 6
This thread is more than 6 months old. Information may be outdated. Consider searching for more recent discussions.
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Nov 11, 2025 at 2:34 PM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

Where I think it is weakest: the subgroup findings are the part I trust least — with enough subgroups something is always significant, and these were not all pre-registered.

The narrow version of the question is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. I have searched first, so if this is covered somewhere point me at it and I will read it.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
48 1Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 45 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Nov 11, 2025 at 2:55 PM#2
pam_stl said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Telehealth prescriber review for cost and coverage: I've used 4 different telehealth platforms to get my GLP-1 prescription. Comparison:

FeaturePlatform APlatform BPlatform C
Initial Consult$74$84$0
Monthly Follow-up$34Included$59
Prescription SpeedSame day24-48 hoursSame day
Lab MonitoringRequiredOptionalRequired

I settled on the one that required labs — it shows they care about safety, not just prescribing volume.

Last edited: Nov 11, 2025 at 3:55 PM
49 2anna.melb_AU, mark_tokyo, hans_munich and 46 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Nov 11, 2025 at 3:16 PM#3
pam_stl said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

Last edited: Nov 11, 2025 at 8:16 PM
50 3ingrid_STO, pete_nash, hank_denver and 47 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Nov 11, 2025 at 3:37 PM#4
NurseKim_ATL said:
The affordability discussion here usually stops at individual tactics.

My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.

1 4lori_vegas
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Nov 11, 2025 at 5:31 PM#5
Dr.RaviCardio said:
Telehealth prescriber review for cost and coverage: I've used 4 different telehealth platforms to get my GLP-1 prescription.

Second this. Posting only so the count is not one.

Last edited: Nov 11, 2025 at 6:31 PM
2 5KristenIndy, MarkLI_maint
Reply Quote Save Share Report
1236

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register